Reuters: Health
An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, early-stage trial, the company said on Sunday.
Amgen drug shrinks lung cancer tumors in half of patients: study
Amgen drug shrinks lung cancer tumors in half of patients: study
Reuters: Health
An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, early-stage trial, the company said on Sunday.
Reuters: Health
An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, early-stage trial, the company said on Sunday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment